Cad a fuair trialacha GLP-1 i ndáiríre

Níl aon roimheanna agus ina dhiaidh sin, níl aon tionchair. Níl ann ach na trialacha randamacha, na méideanna éifeachta, agus na codanna a fhágann an margaíocht amach — gach éileamh nasctha lena thaifead PubMed.

66peer-reviewed citations
42European languages
0sponsored verdicts
Pinn inste á choinneáil i gcoinne port craicinn ar an láimhseachán.
Marius Vassnes · CC BY-SA 4.0 · Wikimedia Commons

Start here

Each page answers one question and shows its working. If you only read one, read the page on stopping — it is the finding that changes how you should think about the whole class.

Mechanism

How GLP-1 drugs actually work

Slower gastric emptying, hypothalamic satiety signalling, and why "it just makes you eat less" is both true and incomplete.

Body composition

How much of the loss is muscle?

Roughly a quarter to a third of the weight lost is lean mass. Whether that matters is a harder question.

Durability

What happens when you stop

Most of the weight comes back within a year. This is the single most important finding in the field.

Outcomes

Does it protect your heart?

SELECT found a 20% reduction in major cardiovascular events — in a population that was not diabetic.

Pipeline

The oral pills

Oral semaglutide and orforglipron: same class, no needle, slightly smaller effect.

Léitheoireacht ghaolmhar

Fasting Evidence

Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.

Metabolism Review

Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.

Weight Loss Evidence

Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.

Sleep Evidence

Sleep, circadian rhythm and the wearables that claim to measure both.

Taispeánadh an leathanach seo go huathoibríoch ó Bhéarla. Ní athraítear na tagairtí agus na huimhreacha. Léigh an t-údarás Béarla má léitear rud ar bith go neamhréireach. Léigh an t-údarás Béarla